We no longer suggest the use of albuterol in the treatment of High Altitude Pulmonary Edema (HAPE). Although there are reports of beta-agonist use in HAPE treatment and the risks of use are low, no data support a benefit from albuterol in patients experiencing HAPE.
Read the WMS Journal publication for more information.
These curricula recommendations have been adopted from NOLS Wilderness Medicine and have been edited to conform to the standards
set by Center for Wilderness Safety and the Wilderness Medical Society in accordance with the WMS National Practice Guidelines.